Cargando…

The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota

BACKGROUND: Helicobacter pylori (H. pylori) infection is associated with remodeling of gut microbiota. Many studies have found H. pylori infection and eradication therapy can alter the gut microbiota. However, few studies explored the impact of eradication therapy containing minocycline and metronid...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Meng-Yan, Cui, Zhen-Yu, Zhao, Meng-Qi, Zhang, Meng-Jie, Jiang, Qiao-Li, Wang, Jing-Jing, Lu, Lun-Gen, Lu, Ying-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798553/
https://www.ncbi.nlm.nih.gov/pubmed/36581836
http://dx.doi.org/10.1186/s12866-022-02732-6
_version_ 1784860928565575680
author Cui, Meng-Yan
Cui, Zhen-Yu
Zhao, Meng-Qi
Zhang, Meng-Jie
Jiang, Qiao-Li
Wang, Jing-Jing
Lu, Lun-Gen
Lu, Ying-Ying
author_facet Cui, Meng-Yan
Cui, Zhen-Yu
Zhao, Meng-Qi
Zhang, Meng-Jie
Jiang, Qiao-Li
Wang, Jing-Jing
Lu, Lun-Gen
Lu, Ying-Ying
author_sort Cui, Meng-Yan
collection PubMed
description BACKGROUND: Helicobacter pylori (H. pylori) infection is associated with remodeling of gut microbiota. Many studies have found H. pylori infection and eradication therapy can alter the gut microbiota. However, few studies explored the impact of eradication therapy containing minocycline and metronidazole on gut microbiota. AIM: The objective of the present study was to explore the changes of gut microbiota after H. pylori infection. Besides, learn more about the dynamic changes of gut microbiota during different stages of eradication treatment containing minocycline, metronidazole, bismuth agents and proton pump inhibitors. METHODS: Sixty stool samples from the patients with H. pylori infection before eradication, 14 and 42 days after eradication, and ten stool samples from non-infected individuals were collected. Subsequently, we performed 16S rRNA gene amplicon sequencing to analyze these samples, and the results were evaluated by using alpha diversity, beta diversity and microbial composition analyses. Phylogenetic Investigation of Communities by Reconstruction of Unobserved States was also used to predict the metabolic pathways according to the Kyoto Encyclopedia of Genes and Genomes database. RESULTS: The alpha and beta diversity of the microbiota changed significantly in H. pylori infected individuals, but returned to baseline 42 days after eradication therapy. At the genus level, the abundances of Bacteroidetes, [Ruminococcus]_gnavus_group, Ruminococcaceae_Incertae_Sedis, Tuzzrealla, Butyricicoccus were significantly lower in the H. pylori infected group. Bacterial abundance was also dynamically changing during eradication treatment. In addition, PICRUST analysis found the levels of uronic acid metabolism, uncharacterized transport system, and biosynthesis of unsaturated fatty acids were higher in H. pylori infected individuals than in the non-infected group. CONCLUSIONS: Intestinal microbiota diversity, composition, functional predictions altered significantly after H. pylori infection, and gradually returned to healthy control levels after the application of eradication therapy containing minocycline and metronidazole in one month and a half. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-022-02732-6.
format Online
Article
Text
id pubmed-9798553
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97985532022-12-30 The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota Cui, Meng-Yan Cui, Zhen-Yu Zhao, Meng-Qi Zhang, Meng-Jie Jiang, Qiao-Li Wang, Jing-Jing Lu, Lun-Gen Lu, Ying-Ying BMC Microbiol Research BACKGROUND: Helicobacter pylori (H. pylori) infection is associated with remodeling of gut microbiota. Many studies have found H. pylori infection and eradication therapy can alter the gut microbiota. However, few studies explored the impact of eradication therapy containing minocycline and metronidazole on gut microbiota. AIM: The objective of the present study was to explore the changes of gut microbiota after H. pylori infection. Besides, learn more about the dynamic changes of gut microbiota during different stages of eradication treatment containing minocycline, metronidazole, bismuth agents and proton pump inhibitors. METHODS: Sixty stool samples from the patients with H. pylori infection before eradication, 14 and 42 days after eradication, and ten stool samples from non-infected individuals were collected. Subsequently, we performed 16S rRNA gene amplicon sequencing to analyze these samples, and the results were evaluated by using alpha diversity, beta diversity and microbial composition analyses. Phylogenetic Investigation of Communities by Reconstruction of Unobserved States was also used to predict the metabolic pathways according to the Kyoto Encyclopedia of Genes and Genomes database. RESULTS: The alpha and beta diversity of the microbiota changed significantly in H. pylori infected individuals, but returned to baseline 42 days after eradication therapy. At the genus level, the abundances of Bacteroidetes, [Ruminococcus]_gnavus_group, Ruminococcaceae_Incertae_Sedis, Tuzzrealla, Butyricicoccus were significantly lower in the H. pylori infected group. Bacterial abundance was also dynamically changing during eradication treatment. In addition, PICRUST analysis found the levels of uronic acid metabolism, uncharacterized transport system, and biosynthesis of unsaturated fatty acids were higher in H. pylori infected individuals than in the non-infected group. CONCLUSIONS: Intestinal microbiota diversity, composition, functional predictions altered significantly after H. pylori infection, and gradually returned to healthy control levels after the application of eradication therapy containing minocycline and metronidazole in one month and a half. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-022-02732-6. BioMed Central 2022-12-29 /pmc/articles/PMC9798553/ /pubmed/36581836 http://dx.doi.org/10.1186/s12866-022-02732-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cui, Meng-Yan
Cui, Zhen-Yu
Zhao, Meng-Qi
Zhang, Meng-Jie
Jiang, Qiao-Li
Wang, Jing-Jing
Lu, Lun-Gen
Lu, Ying-Ying
The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
title The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
title_full The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
title_fullStr The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
title_full_unstemmed The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
title_short The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
title_sort impact of helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798553/
https://www.ncbi.nlm.nih.gov/pubmed/36581836
http://dx.doi.org/10.1186/s12866-022-02732-6
work_keys_str_mv AT cuimengyan theimpactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT cuizhenyu theimpactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT zhaomengqi theimpactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT zhangmengjie theimpactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT jiangqiaoli theimpactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT wangjingjing theimpactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT lulungen theimpactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT luyingying theimpactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT cuimengyan impactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT cuizhenyu impactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT zhaomengqi impactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT zhangmengjie impactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT jiangqiaoli impactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT wangjingjing impactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT lulungen impactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota
AT luyingying impactofhelicobacterpyloriinfectionanderadicationtherapycontainingminocyclineandmetronidazoleonintestinalmicrobiota